Trial · NCT01295294
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The primary efficacy variable will be the cumulative number of bleeding / spotting days | During 90 day double-blind treatment period | |
| Secondary | To describe and compare the bleeding patterns observed in women during treatment period | 90 day treatment period | |
| Secondary | To describe and compare the bleeding patterns observed in women during follow-up period | During the 30 day follow-up period | |
| Secondary | Satisfaction with oral blinded study drug treatment for bleeding / spotting | 90 day treatment period | |
| Secondary | Occurrence of dysmenorrhea | During 120 day study period | |
| Secondary | Continuation rate with study drug | During the 90 day treatment period | |
| Secondary | Continuation rate with Mirena | During 120 day study period | |
| Secondary | Adverse Events Collection | Until day 120 | |
| Secondary | Number of spotting-only days | During the 90-day treatment period | |
| Secondary | Number of bleeding / spotting episodes | During the 90-day treatment period | |
| Secondary | Length of bleeding / spotting episodes | During the 90-day treatment period | |
| Secondary | Number of bleeding days with heavy intensity | During the 90-day treatment period | |
| Secondary | Change in the number of B/S days between Day 60 and Day 90 of MIRENA use and the 30-day follow-up period | Up to day 120 | |
| Secondary | Satisfaction with levonorgestrel-releasing intrauterine system | Up to day 120 | |
| Secondary | Number of days of pain medication for dysmenorrhea during the 90 day treatment period | During the 90-day treatment period | |
| Secondary | Number of bleeding-only days | During the 90-day treatment period |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01295294/registered